Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.